Resette 4-in-1 Skin Tint Serum
- Manufacturer
- Resette | Nanophase Technologies Corporation
- Effective date
- 2024-05-21
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:02:17
Label at a glance#
ProductResette 4-in-1 Skin Tint Serum
Active ingredientZINC OXIDE
Label structure8 sections
Label contents#
Full prescribing information#
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Resette 4-in-1 Skin Tint Serum
Products#
Every source-derived product name is available through these pages.
- Resette 4-in-1 Skin Tint Serum
- Zinc Oxide
- LAURYL PEG-8 DIMETHICONE (300 CPS)
- FERRIC OXIDE YELLOW
- ALKYL (C12-15) BENZOATE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- DIMETHICONE
- WATER
- NIACINAMIDE
- ETHYLHEXYLGLYCERIN
- HEXYLENE GLYCOL
- TRILAURETH-4 PHOSPHATE
- DIMETHICONOL/PROPYLSILSESQUIOXANE/SILICATE CROSSPOLYMER (450000000 MW)
- PROPANEDIOL
- TETRASODIUM GLUTAMATE DIACETATE
- FERRIC OXIDE RED
- SODIUM CHLORIDE
- PHENOXYETHANOL
- BUTYLOCTYL SALICYLATE
- OCTYLDODECYL NEOPENTANOATE
- ISODODECANE
- .ALPHA.-BISABOLOL, (+)-
- ALLANTOIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 82417-1206 | 82417-1206-1, 82417-1206-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 409757c7-fb11-e5fd-e063-6294a90ad7c3 | 18f550ee-e661-0b8a-e063-6294a90a0041 | 2025-10-07 | Warnings | 18f550ee-e661-0b8a-e063-6294a90a0041 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.





